Pacific Biosciences Of California | PACB - Kapitał Własny I Rezerwy





Kapitał Własny I Rezerwy Zmiana Data
Agilent USD 6.91B 167M 2025-12
Bruker USD 2.49B 625.6M 2025-09
Danaher USD 52.95B 415M 2026-03
General Electric Aerospace USD 18.06B 841M 2026-03
Illumina USD 2.68B 47M 2026-03
Myriad Genetics USD 337.4M 30.6M 2026-03
Pacific Biosciences Of California USD 5.35M 30.74M 2025-12
Quidel USD 1.85B 69.1M 2026-03
Revvity USD 7.25B 125.54M 2025-12
Roche Holding CHF 33.8B 758M 2025-12
Standard Biotools USD 424.29M 24.63M 2025-12
Thermo Fisher Scientific USD 51.93B 1.6B 2026-03
Waters USD 2.56B 230.55M 2025-12